<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4388600 Figure_1-B</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>RT&#8208;PCR performed on cDNA from RNA isolated from splenic B cells derived from Tam&#8208;treated mb1&#8208;CreERT2 (left lane) or mb1&#8208;CreERT2;Sykfl/flmice (right lane); the Syk&#8208; and Hprt&#8208;specific amplification products were identified by agarose gel electrophoresis with Hprt used as an endogenous loading control.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_1-C</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoblot analysis of proteins isolated from B cells derived from spleens of mb1&#8208;CreERT2 (left lane) or mb1&#8208;CreERT2;Sykfl/fl (right lane) mice both treated with Tam as described; blots were probed with anti&#8208;Syk and anti&#8208;GAPDH Ab, GAPDH being used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_1-D</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>Intracellular flow cytometric analysis for Syk expression in B cells derived from the LN of Syk&#8208;deficient and control mice.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_1-E</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>Genomic DNA analysis of Tam&#8208;treated mb1&#8208;CreERT2 or mb1&#8208;CreERT2;Sykfl/fl mice (as indicated). Upper row: amplification of floxed (fl) and wt (+) alleles. Middle row: amplification of the deleted (d) allele. Lower row: loading control (TC21, a gene unaffected by the deletion of Syk). Established control DNA was used to visualize the individual bands (as indicated).</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_2-A-E</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 2-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Flow cytometric analysis of B cells from (A) the BM and (B) the SP of mb1&#8208;CreERT2 control (left) and mb1&#8208;CreERT2;Sykfl/flmice (right) treated with Tam as described in the Materials and Methods section. The BM cells were stained with anti&#8208;IgM and anti&#8208;B220, and the SP cells with anti&#8208;CD19 and anti&#8208;CD93 or anti&#8208;CD23 and anti&#8208;CD21. The gated regions in the dot blots correspond to individual B&#8208;cell populations: (A) Bone marrow: gate P (B220+IgM&#8722;) pro&#8208;/pre&#8208;B cells, gate I (B220loIgM+) immature B cells, gate M (B220hiIgM+) mature B cells; (B) spleen: gate T (CD19+ CD93+) transitional B cells (T), gate M (CD19+ CD93&#8722;) mature B cells; in CD93&#8722;splenic B cells, gate M (CD23hiCD21int CD93&#8722;) mature follicular B cells and gate MZ (CD23lo CD21hi CD93&#8722;) marginal zone B cells. The numbers in the dot plots indicate the mean relative frequency of cells in the gate. C-E Statistical analysis of absolute cell numbers per Tam&#8208;treated mouse: filled circles indicating cells obtained from mb1&#8208;CreERT2 control mice and open circles from mb1&#8208;CreERT2;Sykfl/flmice. (C) Statistical analysis of the absolute cell numbers of pro&#8208;/pre&#8208;, immature and mature recirculating B cells in the BM. (D) Absolute cell numbers of transitional, M and MZ B cells found in the SP. (E) Statistical analysis of the absolute cells numbers of peritoneal B cell subsets B1&#8208;a and B1&#8208;b. An asterisk (*) marks statistically significant differences (P  0.05), two asterisks (**) indicate P  0.01, P&#8208;values were obtained using two&#8208;tailed Student's t&#8208;test. Cell numbers of four to five mice per group are shown, with each dot representing an individual animal.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_3-A</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Flow cytometric analysis of IgM, CD19 and CD23 expression of splenic B cells from Tam&#8208;treated mb1&#8208;CreERT2 control (dashed line) and mb1&#8208;CreERT2;Sykfl/flmice (solid line).</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_3-B</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Flow cytometric analysis of tyrosine phosphorylation (pY) in splenic B cells from Tam&#8208;treated mb1&#8208;CreERT2 and mb1&#8208;CreERT2;Sykfl/flmice stimulated with medium (dotted line) or 50 &#956;M pervanadate (dashed and solid lines).</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_3-C-D</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Flow cytometric analysis of the intracellular Ca2+ influx in purified splenic B cells derived from Tam&#8208;treated mice. mb1&#8208;CreERT2 or mb1&#8208;CreERT2;Sykfl/fl were treated with (C) 10 &#956;g/ml anti&#8208;Kappa F(ab&#8242;)2 fragments or (D) 1 &#956;M ionomycin.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_4-A</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Ex vivo activation assay of splenic mature B cells from Tam&#8208;treated mb1&#8208;CreERT2 (upper row) or Tam&#8208;treated mb1&#8208;CreERT2;Sykfl/flmice (lower row). Purified splenic B cells were either left unstimulated (medium) or were stimulated with the indicated stimuli. The cells were analyzed by flow cytometry after 24 h. Shown are CD19 versus CD86 dot plots. 7&#8208;AAD was included to distinguish dead from viable cells. The numbers in the quadrants indicate the relative frequencies of cells in the gate.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_4-B</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Ex vivo proliferation assay with mature B cells from Tam&#8208;treated mb1&#8208;CreERT2 (upper row) or Tam&#8208;treated mb1&#8208;CreERT2;Sykfl/flmice (lower row). The cells were incubated with the indicated stimuli for 90 h.</text>
    </passage>
  </document>
  <document>
    <id>4388600 Figure_5-A-B</id>
    <infon key="sourcedata_document">1994</infon>
    <infon key="doi">10.15252/embj.201489732</infon>
    <infon key="pmc_id">4388600</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Flow cytometric analysis of splenic B cells from Rag2&#8722;/&#8722;;&#947;c&#8722;/&#8722; mice. CD19 versus CD3&#949; dot plots are shown. The mice were injected i.v. with 5 &#215; 106 splenic (CD19+ CD93&#8722;) B cells and (CD3&#949;+) T cells from Tam&#8208;untreated mb1&#8208;CreERT2 control or mb1&#8208;CreERT2;Sykfl/fl mice. The recipient mice were treated with Tam beginning 1 day after transfer as described in the Materials and Methods section. B Quantitative analysis of B and T cells from Rag2&#8722;/&#8722;;&#947;c&#8722;/&#8722; mice repopulated with mb1&#8208;CreERT2 or mb1&#8208;CreERT2;Sykfl/fl splenocytes. Each symbol represents an individual mouse. Filled circles and squares represent Syk+/+ B and T cells, respectively; open circles and squares represent Sykfl/fl B and T cells.</text>
    </passage>
  </document>
</collection>
